Viridian Therapeutics, Inc.

NasdaqCM:VRDN Stock Report

Market Cap: US$1.6b

Viridian Therapeutics, Inc. Company Information

Viridian Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Viridian Therapeutics, Inc.
  • Ticker: VRDN
  • Exchange: NasdaqCM
  • Founded: 2010
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$1.603b
  • Shares Outstanding: 79.21m
  • Website: https://www.viridiantherapeutics.com

Number of Employees

Location

  • Viridian Therapeutics, Inc.
  • 221 Crescent Street
  • Suite 401
  • Waltham
  • Massachusetts
  • 02453
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
VRDNNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDFeb 2017
1S1DB (Deutsche Boerse AG)YesCommon StockDEEURFeb 2017
0K1RLSE (London Stock Exchange)YesCommon StockGBUSDFeb 2017

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/20 18:46
End of Day Share Price 2024/11/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.